1Rothwell N.Interleukin-1 and neuronal injury:mechanisms,modification,and therapeutic potential[J].Brain Behav Immun,2003,17(3):152-157.
2Alvaro-González LC,Freijo-Guerrero MM,Sádaba-Garay F.Inflammatory mechanisms,arteriosclerosis and ischemic stroke:clinical data and perspectives[J].Rev Neurol,2002,35(5):452-462.
3Um JY,Kim HM.Polymorphisms of RANTES and IL-4 genes in cerebral infarction[J].J Mol Neurosci,2009,37(1):1-5.
5Klein RL Ascencao JL Mironova M,et al.Effect of inflammatory cytokines on the metabolism of low-density lipoproteins by human vascular endothelial cells[J].Metabolism,2001,50(1):99-106.
4[1]Rothwell N.Interleukin-1 and neuronal injury:mechanisms,modification,and therapeutic potential.Brain Behav Immun,2003,17:152-157.
5[2]Alvaro-Gonzalez LC,Freijo-Guerrero MM,SadabaGaray F.Inflammatory mechanisms,arteriosclerosis and ischemic stroke:clinical data and perspectives.Rev Neurol,2002,35:452-462.
6[3]Catto A J,Carter AM,Stickland M,et al.Plasminogen activator inhibitor-1 (PAI-1) 4G/5G promoter polymorphism and levels in subjects with cerebrovascular disease.Thromb Haemost,1997,77:730-734.
7[4]Boutin H,LeFeuvre RA,Horai R,et al.Role of IL-1α and IL-1β in ischemic brain damage.J Neurosci,2001,21:5528-5534.
8[5]Um JY,Moon KS,Lee KM,et al.Association of interleukin-1 α gene polymorphism with cerebral infarction.Brain Res Mol Brain Res,2003,115:50-54.
9[6]Bioque G,Crusius JB,Koutroubakis I,et al.Allelic polymorphism in IL-1β and IL-1 receptor antagonist (IL-1Ra) genes in inflammatory bowel disease.Clin Exp Immunol,1995,102:379-383.
10[7]Witkin SS,Gerber S,Ledger WJ.Influence of interleukin-1 receptor antagonist gene polymorphism on disease.Clin Infect Dis,2002,34:204-209.
